XML 78 R67.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidating Financial Information - Summary of Condensed Consolidating Cash Flows (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net cash provided by (used in) operating activities $ 191,612 $ 182,621
Cash flows from investing activities:    
Exploration, development, and other capital expenditures (154,628) (229,601)
Cash paid for acquisitions, net of cash acquired (296,966) (32,916)
Proceeds from sale of other property and equipment   5,369
Net cash provided by (used in) investing activities (451,594) (257,148)
Cash flows from financing activities:    
Redemption of Senior Notes and other long-term debt (1,209) (10,567)
Proceeds from Bank Credit Facility 300,000 75,000
Repayment of Bank Credit Facility   (25,000)
Deferred financing costs (1,287)  
Other deferred payments (7,575) (9,921)
Payment of capital lease (8,323) (6,759)
Employee stock transactions (791) (283)
Net cash provided by (used in) financing activities 280,815 22,470
Net increase (decrease) in cash, cash equivalents and restricted cash 20,833 (52,057)
Cash, cash equivalents and restricted cash:    
Balance, beginning of period 87,022 141,162
Balance, end of period 107,855 89,105
Parent    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (324) (259)
Cash flows from financing activities:    
Capital contributions 331 259
Distributions to Subsidiary Issuer (7)  
Net cash provided by (used in) financing activities 324 259
Subsidiary Issuer    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 49,486 (59,988)
Cash flows from investing activities:    
Exploration, development, and other capital expenditures (1,791) (1,442)
Investments in subsidiaries (783,703) (784,698)
Distributions from subsidiaries 462,034 838,920
Net cash provided by (used in) investing activities (323,460) 52,780
Cash flows from financing activities:    
Redemption of Senior Notes and other long-term debt (1,209)  
Proceeds from Bank Credit Facility 300,000 75,000
Repayment of Bank Credit Facility   (25,000)
Deferred financing costs (1,287)  
Employee stock transactions   (283)
Net cash provided by (used in) financing activities 297,504 49,717
Net increase (decrease) in cash, cash equivalents and restricted cash 23,530 42,509
Cash, cash equivalents and restricted cash:    
Balance, beginning of period 78,780 13,541
Balance, end of period 102,310 56,050
Guarantors    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 154,079 266,802
Cash flows from investing activities:    
Exploration, development, and other capital expenditures (149,621) (207,340)
Cash paid for acquisitions, net of cash acquired (296,966) (32,916)
Proceeds from sale of other property and equipment   5,369
Net cash provided by (used in) investing activities (446,587) (234,887)
Cash flows from financing activities:    
Redemption of Senior Notes and other long-term debt   (10,567)
Other deferred payments (7,575) (9,921)
Payment of capital lease (8,323) (6,759)
Employee stock transactions (791)  
Capital contributions 770,872 734,939
Distributions to Subsidiary Issuer (460,477) (838,595)
Net cash provided by (used in) financing activities 293,706 (130,903)
Net increase (decrease) in cash, cash equivalents and restricted cash 1,198 (98,988)
Cash, cash equivalents and restricted cash:    
Balance, beginning of period 593 102,049
Balance, end of period 1,791 3,061
Non-Guarantors    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (11,629) (23,934)
Cash flows from investing activities:    
Exploration, development, and other capital expenditures (3,216) (20,819)
Net cash provided by (used in) investing activities (3,216) (20,819)
Cash flows from financing activities:    
Capital contributions 12,500 49,500
Distributions to Subsidiary Issuer (1,550) (325)
Net cash provided by (used in) financing activities 10,950 49,175
Net increase (decrease) in cash, cash equivalents and restricted cash (3,895) 4,422
Cash, cash equivalents and restricted cash:    
Balance, beginning of period 7,649 25,572
Balance, end of period 3,754 29,994
Elimination    
Cash flows from investing activities:    
Investments in subsidiaries 783,703 784,698
Distributions from subsidiaries (462,034) (838,920)
Net cash provided by (used in) investing activities 321,669 (54,222)
Cash flows from financing activities:    
Capital contributions (783,703) (784,698)
Distributions to Subsidiary Issuer 462,034 838,920
Net cash provided by (used in) financing activities $ (321,669) $ 54,222